Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-25-Speech-2-267-750"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20111025.25.2-267-750"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Since the Court of Auditors, in its report on the annual accounts of the European Medicines Agency for the financial year 2009, qualified its opinion on the legality and regularity of the underlying transactions, Parliament decided, in its decision of 10 May 2011, to postpone its decision on granting the Executive Director of the agency discharge in respect of the implementation of the agency’s budget for the financial year 2009. The discharge authority subsequently received replies from the agency following Parliament’s resolution of 10 May 2011, and in its replies, the agency provided updated information on the implementation of recommendations. In light of the second report of the Committee on Budgetary Control, the Executive Director of the European Medicines Agency was granted discharge in respect of the implementation of the agency’s budget for the financial year 2009
The discharge authority shall continue to carefully monitor, during the upcoming discharge procedures, the level of implementation of the measures undertaken to address the agency’s serious weaknesses disclosed by the reports from both the Court of Auditors and the Internal Audit Service. It is therefore desirable for the agency to continue informing the discharge authority of the measures implemented and their results, and always to submit the requested documents on time."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples